• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大肠系膜切除术降低克罗恩病手术复发率:一项系统评价和荟萃分析

Extended mesenteric resection reduces the rate of surgical recurrence in Crohn's disease: a systematic review and meta-analysis.

作者信息

Vaghiri Sascha, Alipouriani Ali, Knoefel Wolfram Trudo, Kessler Hermann, Prassas Dimitrios

机构信息

Department of Surgery (A), Heinrich-Heine-University, Medical Faculty and University Hospital Duesseldorf, Moorenstr. 5, Bldg. 12.46, 40225, Duesseldorf, Germany.

Department for Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.

出版信息

Int J Colorectal Dis. 2025 Feb 25;40(1):51. doi: 10.1007/s00384-025-04845-6.

DOI:10.1007/s00384-025-04845-6
PMID:39998692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11861228/
Abstract

PURPOSE

Mesenteric resection in Crohn's disease (CD) is still controversial and under discussion. We performed a meta-analysis to assess recurrence rates and operative-related morbidity based on the extent of mesenteric resection.

METHODS

A comprehensive literature research was conducted until November 2024 using PubMed (Medline), the Cochrane Central trials register, and Google Scholar databases. Studies before the biological era or with Kono-S anastomosis were excluded. Data from comparative studies with reported patient characteristics and outcome results of extended and limited mesenteric resections were extracted and subsequently entered into a pairwise meta-analysis model. Odds ratios (ORs) for dichotomous variables and standardized mean differences (SMDs) for continuous outcomes with 95% confidence intervals (CIs) were calculated. The risk of bias was rated according to ROBINS-I and Rob2 criteria, respectively.

RESULTS

Four non-randomized studies and one randomized trial with a total of 4358 patients (extended mesenteric resection: n = 993 versus mesenteric preservation: n = 3365) met eligibility criteria and were included. Extended mesenteric resection was significantly associated with reduced surgical recurrence rates compared to mesenteric preservation (OR = 4.94; 95% CI [2.22-10.97]; p < 0.001, I = 0%). In terms of endoscopic recurrence, postoperative morbidity, and hospital stay, no significant differences between both groups were noted within the short follow-up period.

CONCLUSION

Extended mesenteric resection demonstrated a lower surgical recurrence rate in Crohn's disease, while morbidity rates were comparable to the mesenteric sparing approach, whether extended mesenteric excision should be recommended requires further high-quality randomized trials with long-term follow-up data.

摘要

目的

克罗恩病(CD)的肠系膜切除术仍存在争议且有待探讨。我们进行了一项荟萃分析,以评估基于肠系膜切除范围的复发率和手术相关发病率。

方法

截至2024年11月,使用PubMed(Medline)、Cochrane中心试验注册库和谷歌学术数据库进行了全面的文献检索。排除生物治疗时代之前或采用Kono-S吻合术的研究。提取了具有报告的患者特征以及扩大和有限肠系膜切除术结果的比较研究数据,随后将其纳入成对荟萃分析模型。计算二分变量的比值比(OR)和连续结果的标准化均值差(SMD),并给出95%置信区间(CI)。分别根据ROBINS-I和Rob2标准对偏倚风险进行评级。

结果

四项非随机研究和一项随机试验,共4358例患者(扩大肠系膜切除术:n = 993例;保留肠系膜:n = 3365例)符合纳入标准并被纳入。与保留肠系膜相比,扩大肠系膜切除术与手术复发率降低显著相关(OR = 4.94;95%CI[2.22 - 10.97];p < 0.001,I = 0%)。在内镜复发、术后发病率和住院时间方面,两组在短期随访期内未发现显著差异。

结论

扩大肠系膜切除术在克罗恩病中显示出较低的手术复发率,而发病率与保留肠系膜的方法相当,是否应推荐扩大肠系膜切除术需要进一步的高质量随机试验及长期随访数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/bff206480288/384_2025_4845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/622f53ecc073/384_2025_4845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/d887c88ee4f7/384_2025_4845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/bff206480288/384_2025_4845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/622f53ecc073/384_2025_4845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/d887c88ee4f7/384_2025_4845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed4c/11861228/bff206480288/384_2025_4845_Fig3_HTML.jpg

相似文献

1
Extended mesenteric resection reduces the rate of surgical recurrence in Crohn's disease: a systematic review and meta-analysis.扩大肠系膜切除术降低克罗恩病手术复发率:一项系统评价和荟萃分析
Int J Colorectal Dis. 2025 Feb 25;40(1):51. doi: 10.1007/s00384-025-04845-6.
2
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial.保留肠系膜或扩大切除术对克罗恩病原发性回肠结肠切除术后内镜复发的影响(SPICY):一项国际随机对照试验。
Lancet Gastroenterol Hepatol. 2024 Sep;9(9):793-801. doi: 10.1016/S2468-1253(24)00097-9. Epub 2024 Jul 15.
3
Clinical outcomes of conventional versus extended mesenteric resection in limited ileo-colonic Crohn's disease: a systematic review and meta-analysis.局限性回结肠克罗恩病中传统与扩大肠系膜切除术的临床结局:一项系统评价与荟萃分析
Int J Colorectal Dis. 2025 Jun 18;40(1):144. doi: 10.1007/s00384-025-04937-3.
4
Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.维持克罗恩病手术诱导缓解的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2019 Sep 12;9(9):CD013210. doi: 10.1002/14651858.CD013210.pub2.
5
Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。
Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.
6
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.硫唑嘌呤和6-巯基嘌呤用于维持克罗恩病手术诱导的缓解状态
Cochrane Database Syst Rev. 2014 Aug 1;2014(8):CD010233. doi: 10.1002/14651858.CD010233.pub2.
7
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
8
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于维持克罗恩病的缓解状态。
Cochrane Database Syst Rev. 2015 Oct 30;2015(10):CD000067. doi: 10.1002/14651858.CD000067.pub3.
9
Enteral nutritional therapy for induction of remission in Crohn's disease.肠内营养疗法诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD000542. doi: 10.1002/14651858.CD000542.pub3.
10
Low dose naltrexone for induction of remission in Crohn's disease.低剂量纳曲酮诱导克罗恩病缓解
Cochrane Database Syst Rev. 2018 Apr 1;4(4):CD010410. doi: 10.1002/14651858.CD010410.pub3.

引用本文的文献

1
Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.肥胖介导的炎症及其对炎症性肠病的影响:病理生理学、临床影响及治疗意义
Biomolecules. 2025 Aug 18;15(8):1185. doi: 10.3390/biom15081185.
2
Clinical outcomes of conventional versus extended mesenteric resection in limited ileo-colonic Crohn's disease: a systematic review and meta-analysis.局限性回结肠克罗恩病中传统与扩大肠系膜切除术的临床结局:一项系统评价与荟萃分析
Int J Colorectal Dis. 2025 Jun 18;40(1):144. doi: 10.1007/s00384-025-04937-3.

本文引用的文献

1
Mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease.克罗恩病初次回结肠切除术中的肠系膜保留或扩大切除
Lancet Gastroenterol Hepatol. 2025 Jan;10(1):15-16. doi: 10.1016/S2468-1253(24)00343-1.
2
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel.成人炎症性肠病的内镜诊断与管理:美国胃肠内镜学会炎症性肠病内镜共识小组的共识文件
Gastrointest Endosc. 2025 Feb;101(2):295-314. doi: 10.1016/j.gie.2024.08.034. Epub 2024 Oct 18.
3
Effect of Kono-S anastomosis on reducing postoperative recurrence rates in Crohn's disease: a systematic review and meta-analysis.
Kono-S 吻合术对降低克罗恩病术后复发率的影响:系统评价和荟萃分析。
Tech Coloproctol. 2024 Sep 18;28(1):127. doi: 10.1007/s10151-024-02991-7.
4
Safety and effectivity of Kono-S anastomosis in Crohn's patients: a systematic review and Meta-analysis.克罗恩病患者中使用 Kono-S 吻合术的安全性和有效性:系统评价和 Meta 分析。
Langenbecks Arch Surg. 2024 Jul 22;409(1):227. doi: 10.1007/s00423-024-03412-x.
5
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial.保留肠系膜或扩大切除术对克罗恩病原发性回肠结肠切除术后内镜复发的影响(SPICY):一项国际随机对照试验。
Lancet Gastroenterol Hepatol. 2024 Sep;9(9):793-801. doi: 10.1016/S2468-1253(24)00097-9. Epub 2024 Jul 15.
6
How Reliable Is Endoscopic Scoring of Postoperative Recurrence in Crohn Disease?: A Systematic Review and Meta-Analysis.克罗恩病术后复发的内镜评分有多可靠?:一项系统评价与Meta分析
Ann Surg Open. 2024 Mar 18;5(1):e397. doi: 10.1097/AS9.0000000000000397. eCollection 2024 Mar.
7
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.ECCO 指南:克罗恩病治疗——手术治疗。
J Crohns Colitis. 2024 Oct 15;18(10):1556-1582. doi: 10.1093/ecco-jcc/jjae089.
8
Positive resection margins in Crohn's disease are a relevant risk factor for postoperative disease recurrence.克罗恩病中阳性切缘是术后疾病复发的一个相关危险因素。
Sci Rep. 2024 May 11;14(1):10823. doi: 10.1038/s41598-024-61697-w.
9
Mesenteric-based surgery for Crohn's disease: evidence and perspectives.基于肠系膜的克罗恩病手术治疗:证据与展望。
Surgery. 2024 Jul;176(1):51-59. doi: 10.1016/j.surg.2024.02.025. Epub 2024 Apr 8.
10
Extended versus limited mesenteric excision for operative Crohn's disease: 30-Day outcomes from the ACS-NSQIP database.扩大与有限肠系膜切除术治疗手术克罗恩病:ACS-NSQIP 数据库的 30 天结局。
Int J Colorectal Dis. 2023 Nov 18;38(1):268. doi: 10.1007/s00384-023-04561-z.